Diclofenac (Voltaren)-Induced Eosinophilic Pneumonitis
- 26 July 1993
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 153 (14) , 1649-1652
- https://doi.org/10.1001/archinte.1993.00410140031004
Abstract
This report describes dyspnea, cough, erythema multiforme, and a diffuse pulmonary interstitial infiltrate associated with eosinophilic alveolitis in a 67-year-old man taking diclofenac sodium (Voltaren). Onset of these pulmonary abnormalities after beginning diclofenac therapy implicates this drug, which, to our knowledge, has not been described previously to cause eosinophilic pneumonitis. The current report expands the spectrum of nonsteroidal anti-inflammatory drug—induced eosinophilic pneumonitis and reviews available experience with other implicated nonsteroidal anti-inflammatory drugs. (Arch Intern Med. 1993;153:1649-1652)This publication has 12 references indexed in Scilit:
- Rash and pulmonary eosinophilia associated with fenbufen.BMJ, 1990
- Pulmonary Infiltrates Associated with Sulindac TherapyChest, 1990
- PULMONARY INFILTRATIONS INDUCED BY TOLFENAMIC ACIDThe Lancet, 1987
- PULMONARY ALVEOLITIS AND NSAIDS–FACT OR FICTION?Rheumatology, 1986
- Pulmonary Infiltrates with Eosinophilia due to NaproxenChest, 1983
- Sulindac and PneumonitisAnnals of Internal Medicine, 1981
- Pulmonary Reactions to DrugsMedical Clinics of North America, 1977
- Lung changes associated with phenylbutazone treatment.BMJ, 1976
- Letter: diffuse pulmonary disorder caused by oxyphenbutazone.BMJ, 1975
- The Spectrum of Drug-Induced Pulmonary DiseaseAnnals of Internal Medicine, 1972